In 2009, the Canadian Rheumatology Association (CRA) became the major shareholder of The Journal of Rheumatology Publishing Company Limited, the main holding of which was The Journal of Rheumatology. The CRA made the decision to do this because The Journal was a much-valued publication with an international face, and it was and still is the full intention of the CRA to hold the course.
One of the greatest assets to this acquisition was the Editor-in-Chief, Dr. Duncan Alexander Gordon. Duncan has been at the helm of The Journal since 1979, when he stepped in after the untimely death of The Journal’s founder, Dr. Metro Ogryzlo. The Journal has maintained its international flavor because Duncan knew everyone. Standing at his side at an international convention was like standing in the greeting line at a wedding. His editorial board stretched from Amsterdam to …